Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer
Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma. There is a great clinical ...
16 hours ago
0
3









